Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Narayanakutty Warrier"'
Autor:
Mohan Bajranglal Agarwal, Manthanathu Joseph John, Punit Jain, Ashok Kumar Vaid, Ajay Bapna, Maheboob Basade, Palanki Satya Dattatreya, Anupam Chakrapani, Vijay Ramanan, R. Varadarajan, Murali Subramanian, Chirag Aniruddha Shah, Narayanakutty Warrier, Subhaprakash Sanyal, Tyavanagi Shankarmurthy Ashwin, Nagendra Ramanjinappa
Publikováno v:
Indian Journal of Medical and Paediatric Oncology.
Management of chronic myeloid leukemia (CML) has been transformed by the use of tyrosine kinase inhibitors (TKIs). Presently in India, five TKIs are approved for the management of CML with distinct safety profiles. The selection of TKIs for chronic p
Autor:
Agarwal, Mohan Bajranglal1 (AUTHOR) mbagarwal1@gmail.com, John, Manthanathu Joseph2 (AUTHOR), Jain, Punit3 (AUTHOR), Vaid, Ashok Kumar4 (AUTHOR), Bapna, Ajay5 (AUTHOR), Basade, Maheboob6 (AUTHOR), Dattatreya, Palanki Satya7 (AUTHOR), Chakrapani, Anupam8 (AUTHOR), Ramanan, Vijay9 (AUTHOR), Varadarajan, R.10 (AUTHOR), Subramanian, Murali11 (AUTHOR), Shah, Chirag Aniruddha12 (AUTHOR), Warrier, Narayanakutty13 (AUTHOR), Sanyal, Subhaprakash14 (AUTHOR), Ashwin, Tyavanagi Shankarmurthy15 (AUTHOR), Ramanjinappa, Nagendra15 (AUTHOR)
Publikováno v:
Indian Journal of Medical & Paediatric Oncology. Aug2024, Vol. 45 Issue 4, p279-285. 7p.